At age 47, Eric Lefkofsky wasn’t looking to build a new startup and take it all the way through the IPO process. One of Chicago’s most-successful startup founders, Lefkofsky has already founded InnerWorkings, Echo Global Logistics, and local marketing giant Groupon. But when his wife Elizabeth was diagnosed with breast cancer, his exposure to the healthcare system for cancer patients inspired him to create Tempus, a medical start-up with the goal of disrupting cancer treatment and outdated health technology models.
Lefkofsky is betting his own money on the self-funded startup. He told ChicagoInno that Tempus has a huge opportunity success because it was born out of a “problem that needed a solution.” Going to medical appointments with his wife Elizabeth, Lefkofsky was stunned to realize that the technology doctors were using to determine how to treat her cancer was much inferior to technology his company Echo Global Logistics had developed to help truck drivers.
How was it possible, Lefkofsky wondered, that truck drivers had better technology than physicians who were charged with saving a cancer patient’s life?
Eric Lefkofsky and his business partner Brad Keywell, who is CEO of predictive analytics startup Uptake, envisioned a way that genomic sequencing data and machine learning could work together to give doctors a better picture of the information they needed to make the best treatment plans for cancer patients with . After 18 months, Tempus has partnered with approximately a dozen leading organizations in cancer treatment, including the University of Chicago, Northwestern, and the Mayo Clinic. Physicians at the clinics can refer a cancer patient to Tempus. The patients will have their genomic data sequenced at Tempus’ lab. The data is then paired with clinical treatment information and historical data and returned to the referring physician, who also receives access to Tempus’ operating system.
Tempus is “the most meaningful in every metric,” Lefkofsky told ChicagoInno editor Jim Dallke. The company has the opportunity to be bigger than any of Lefkofsky’s other startups which have successfully disrupted their sectors, like Groupon with local commerce and InnerWorkings with marketing.
Dr. Coleman is leading doctor at the Lung Institute. He has clarified to all how stem cell technology is able to reshape the way in which medicine is being practiced today in the U.S.
Dr. Coleman has made a very strong point that today in the U.S.; research is being funded mainly by the biotechnology companies in addition to the government. Besides, all the regulatory agencies are under the direct control of the government. All the expenses for these procedures are getting passed on to the consumer along with the insurance companies. He also discussed that global advancement along with application has ensured that these expenses are not getting passed in a fair manner. This forces many patients to look for treatment from a few sources that may not be so well-controlled. This makes the scientists and caregivers, self-appointed guardians of any material and knowledge related to stem cell research and treatment. They will have only moral along with ethical concerns to guide them.
Ultimately, Dr. Coleman talks about Lung Institute which believes in providing the safest treatment to patients that can relieve their pain and suffering. The best treatment is given which can prolong their quality of life.
After all, the world is getting smaller. According to lifestylesafter50.com, this means that knowledge is getting more egalitarian. All across nations, medical care is becoming more standardized. This is why the Lung Institute already believes that healthcare development has to move from bench to bedside. Thus healthcare will have to progress. It will have to move much beyond national sovereignty. This can be possible only through a global effort.
The Lung Institute has already made a name for being the leader in providing regenerative cellular therapy, https://lunginstitute.com/treatment/. This is for lung diseases that include chronic obstructive pulmonary disease (COPD), besides pulmonary fibrosis as well as interstitial lung disease. The Lung Institute has already treated over 3,000 patients. It was in 2013 that the Lung Institute opened in Tampa, Fla. Now, it has opened a number of clinics in Tampa, Fla., Nashville, Tenn., as well as Scottsdale, Ariz., along with Pittsburgh, Pa. besides Dallas, Texas.
Check out the Lung Institute’s YouTube channel for more information.